The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).
Age greater than or equal to 18
Completed pregnancy with delivery of a live born infant(s). Pregnancies with multiple gestations will be included
No prior history of type 1 or type 2 diabetes
GDM diagnosis by standard screening at 24-28 weeks
None
Single group
Blinded Continuous Glucose Monitoring Device
DeviceSubjects will be asked to wear blinded continuous glucose monitoring device for 14 days.
Determine the ability of continuous glucose monitoring to predict dysglycemia
Assess the validity of the continuous glucose monitoring metrics (percentage) proposed by Cabrera et al. (percent time \>180 of \>4%)
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
